Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Nov;12(5):1098–1103. doi: 10.1128/iai.12.5.1098-1103.1975

Enhanced resistance to Corynebacterium pseudotuberculosis infections associated with reduced serum immunoglobulin levels in levamisole-treated mice.

M R Irwin, H D Knight
PMCID: PMC415403  PMID: 1193726

Abstract

The effect of levamisole (1-2,3,5,6-tetrahydro-6-imidazo[2,1-b]thiazole monohydrochloride) treatment on the course of a Corynebacterium pseudotuberculosis infection and the ability of either vaccinated or unvaccinated randomly bred mice to resist challenge were investigated. It was found that either a double treatment of levamisole administered with or without a sublethal inoculation of C. pseudotuberculosis or a single treatment of levamisole alone had a significant effect on the ability of mice to resist challenge with virulent C. pseudotuberculosis. This prolonged, enhanced nonspecific and specific resistance was associated with a quantitative reduction in the geometric mean serum immunoglobulin levels, with the immunoglobulin G2 and immunoglobulin A levels being more severely affected. As the enhanced nonspecific resistance to C. pseudotuberculosis was associated with depressed serum immunoglobulin levels in the mice pretreated with levamisole alone, it was suggested that the cell-mediated immunity may play a more important role than the humoral immunity in the resistance to C. pseudotuberculosis infection.

Full text

PDF
1098

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENHAM C. L., SEAMAN A., WOODBINE M. Corynebacterium pseudotuberculosis and its role in diseases of animals. Vet Bull. 1962 Oct;32:645–657. [PubMed] [Google Scholar]
  2. Brugmans J., Schuermans V., De Cock W., Thienpont D., Janssen P., Verhaegen H., Van Nimmen L., Louwagie A. C., Stevens E. Restoration of host defense mechanisms in man by levamisole. Life Sci. 1973 Dec 1;13(11):1499–1504. doi: 10.1016/0024-3205(73)90137-9. [DOI] [PubMed] [Google Scholar]
  3. Cameron C. M., Engelbrecht M. M. Mechanism of immunity to Corynebacterium pseudotuberculosis (Buchanan, 1911) in mice using inactivated vaccine. Onderstepoort J Vet Res. 1971 Jun;38(2):73–81. [PubMed] [Google Scholar]
  4. Cameron C. M., Fuls W. J. Studies on the enhancement of immunity to Corynebacterium pseudotuberculosis. Onderstepoort J Vet Res. 1973 Sep;40(3):105–113. [PubMed] [Google Scholar]
  5. Cameron C. M., Minnaar J. L. Immunization of mice against Corynebacterium pseudotuberculosis infection. Onderstepoort J Vet Res. 1969 Dec;36(2):207–210. [PubMed] [Google Scholar]
  6. De Cree J., Verhaegen H., De Cock W., Vanheule R., Brugmans J., Schuermans V. Letter: Impaired neutrophil phagocytosis. Lancet. 1974 Aug 3;2(7875):294–295. doi: 10.1016/s0140-6736(74)91464-0. [DOI] [PubMed] [Google Scholar]
  7. Fisher G. W., Oi V. T., Kelley J. L., Podgore J. K., Bass J. W., Wagner F. S., Gordon B. L., 2nd Enhancement of host defense mechanisms against gram-positive pyogenic coccal infections with levo-tetramisole (levamisole) in neonatal rats. Ann Allergy. 1974 Oct;33(4):193–198. [PubMed] [Google Scholar]
  8. Hard G. C. Adoptive transfer of immunity in experimental Corynebacterium ovis infection. J Comp Pathol. 1970 Apr;80(2):329–334. doi: 10.1016/0021-9975(70)90103-9. [DOI] [PubMed] [Google Scholar]
  9. Hard G. C. Immunity to experimental infection with Corynebacterium ovis in the mouse peritoneal cavity. Res Vet Sci. 1969 Nov;10(6):547–554. [PubMed] [Google Scholar]
  10. Hoebeke J., Franchi G. Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc. 1973 Sep;14(3):317–323. [PubMed] [Google Scholar]
  11. Jolly R. D. The pathogenesis of experimental Corynebacterium ovis infection in mice. N Z Vet J. 1965 Dec;13(6):141–147. doi: 10.1080/00480169.1965.33618. [DOI] [PubMed] [Google Scholar]
  12. Oliveira Lima A., Javierre M. Q., Dias da Silva W., Sette Camara D. Immunological phagocytosis: effect of drugs on phosphodiesterase activity. Experientia. 1974 Aug 15;30(8):945–946. doi: 10.1007/BF01938377. [DOI] [PubMed] [Google Scholar]
  13. Renoux G., Renoux M. Antigenic competition and nonspecific immunity after a rickettsial infection in mice: restoration of antibacterial immunity by phenyl-imidothiazole treatment. J Immunol. 1972 Oct;109(4):761–765. [PubMed] [Google Scholar]
  14. Renoux G., Renoux M. Effet immunostimulant d'un Imidothiazole dans l'immunisation des souris contre l'infection par Brucella abortus. C R Acad Sci Hebd Seances Acad Sci D. 1971 Jan 11;272(2):349–350. [PubMed] [Google Scholar]
  15. Renoux G., Renoux M. Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice. Nat New Biol. 1972 Dec 13;240(102):217–218. doi: 10.1038/newbio240217a0. [DOI] [PubMed] [Google Scholar]
  16. Renoux G., Renoux M. Modulation of immune reactivity by phenylimidothiazole salts in mice immunized by sheep red blood cells. J Immunol. 1974 Sep;113(3):779–790. [PubMed] [Google Scholar]
  17. Renoux G., Renoux M. Stimulation of anti-Brucella vaccination in mice by tetramisole, a phenyl-imidothiazole salt. Infect Immun. 1973 Oct;8(4):544–548. doi: 10.1128/iai.8.4.544-548.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. SHORTLEY G., WILKINS J. R. INDEPENDENT-ACTION AND BIRTH-DEATH MODELS IN EXPERIMENTAL MICROBIOLOGY. Bacteriol Rev. 1965 Mar;29:102–141. doi: 10.1128/br.29.1.102-141.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sawyer M., Osburn B. I., Knight H. D., Kendrick J. W. A quantitative serologic assay for diagnosing congenital infections of cattle. Am J Vet Res. 1973 Oct;34(10):1281–1284. [PubMed] [Google Scholar]
  20. Thienpont D., Vanparijs O. F., Raeymaekers A. H., Vandenberk J., Demoen J. A., Allewijn F. T., Marsboom R. P., Niemegeers C. J., Schellekens K. H., Janssen P. A. Tetramisole (R 8299), a new, potent broad spectrum anthelmintic. Nature. 1966 Mar 12;209(5028):1084–1086. doi: 10.1038/2091084a0. [DOI] [PubMed] [Google Scholar]
  21. Tripodi D., Parks L. C., Brugmans J. Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer. N Engl J Med. 1973 Aug 16;289(7):354–357. doi: 10.1056/NEJM197308162890707. [DOI] [PubMed] [Google Scholar]
  22. Van Ginckel R. F., Hoebeke J. Carbon clearance enhancing factor in serum from levamisole treated mice. J Reticuloendothel Soc. 1975 Feb;17(2):65–72. [PubMed] [Google Scholar]
  23. Versijp G., van Zwet T. L., van Furth R. Letter: Levamisole and functions of peritoneal macrophages. Lancet. 1975 Apr 5;1(7910):798–798. doi: 10.1016/s0140-6736(75)92457-5. [DOI] [PubMed] [Google Scholar]
  24. Woods W. A., Siegel M. J., Chirigos M. A. In vitro stimulation of spleen cell cultures by poly I: poly C and levamisole. Cell Immunol. 1974 Nov;14(2):327–331. doi: 10.1016/0008-8749(74)90217-2. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES